Dynavax Technologies (DVAX) Other Operating Expenses: 2009-2025
Historic Other Operating Expenses for Dynavax Technologies (DVAX) over the last 10 years, with Sep 2025 value amounting to $14.4 million.
- Dynavax Technologies' Other Operating Expenses rose 10.08% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.6 million, marking a year-over-year increase of 48.88%. This contributed to the annual value of $49.4 million for FY2024, which is 19.58% down from last year.
- Latest data reveals that Dynavax Technologies reported Other Operating Expenses of $14.4 million as of Q3 2025, which was up 2.62% from $14.0 million recorded in Q2 2025.
- Over the past 5 years, Dynavax Technologies' Other Operating Expenses peaked at $82.4 million during Q2 2022, and registered a low of $8.7 million during Q4 2023.
- Its 3-year average for Other Operating Expenses is $14.9 million, with a median of $13.4 million in 2024.
- In the last 5 years, Dynavax Technologies' Other Operating Expenses surged by 2,195.39% in 2021 and then crashed by 88.79% in 2023.
- Quarterly analysis of 5 years shows Dynavax Technologies' Other Operating Expenses stood at $74.0 million in 2021, then rose by 4.70% to $77.5 million in 2022, then plummeted by 88.79% to $8.7 million in 2023, then spiked by 54.33% to $13.4 million in 2024, then grew by 10.08% to $14.4 million in 2025.
- Its Other Operating Expenses stands at $14.4 million for Q3 2025, versus $14.0 million for Q2 2025 and $24.7 million for Q1 2025.